Methodology

All entries for: GEn1E Lifesciences

December 23, 2025

GEn1E Lifesciences

Investment

GEn1E Lifesciences raised $5.52 million to accelerate first in class precision therapies for inflammatory & rare diseases.

Disease Area: Rare Disease
Source
Source
October 21, 2025

GEn1E Lifesciences

Investment

GEn1E Life Sciences raised $11.5 million to accelerate first in class precision therapies for inflammatory & rare diseases.

Disease Area: Rare Diseases
Source
Source
Scroll to Top